AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Met G 2mg/500mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Shalman Pharma Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Met G 2mg/500mg Tablet ER

This extended-release tablet, containing 2mg of one medication and 500mg of another, is classified as an antidiabetic agent. It's a dual-action formulation for managing type 2 diabetes in adults, effectively regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal results. Dosage is determined individually by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with seemingly controlled blood sugar, as abrupt cessation can lead to dangerously elevated glucose levels, potentially resulting in kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is one component of a comprehensive diabetes management plan, requiring a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, lightheadedness, headache, and tremors. Learn to recognize these symptoms and treat them promptly with a fast-acting sugar source. Consistent mealtimes and carrying glucose tablets or juice are recommended. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before initiating treatment. Pregnant or lactating women require medical consultation before use. Regular blood glucose monitoring is essential, along with potential blood tests to assess blood cell counts and liver function.

Uses of Met G 2mg/500mg Tablet ER

Managing type 2 diabetes

Major Benefits of Met G 2mg/500mg Tablet ER:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or breaking it. Consumption of Met G 2mg/500mg Extended-Release Tablets should coincide with meals.

Common Side effects of Met G 2mg/500mg Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Met G 2mg/500mg Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Met G 2mg/500mg Extended-Release tablet should be administered with a meal.

How Met G 2mg/500mg Tablet ER works:

Each Met G 2mg/500mg extended-release tablet contains glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use and Met G 2mg/500mg ER tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Met G 2mg/500mg tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Met G 2mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use the extended-release Met G 2mg/500mg tablet cautiously, potentially requiring dosage modification. Physician consultation is essential. This medication is contraindicated in patients with severe renal dysfunction. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Met G 2mg/500mg Extended-Release tablets cautiously. Dosage modification of Met G 2mg/500mg Extended-Release tablets may be necessary. Physician consultation is advised. For those with mild to moderate liver disease, Met G 2mg/500mg Extended-Release tablets are typically initiated at a low dosage; however, their use is contraindicated in patients with severe liver disease.

What if you forget to take Met G 2mg/500mg Tablet ER :

Should you forget to take a Met G 2mg/500mg Extended-Release tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Met G 2mg/500mg Tablet ER

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Met G 2mg/500mg Tablet ER

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Metformin (Met G 2mg/500mg Tablet ER) can cause lactic acidosis, a serious, potentially life-threatening condition involving excessive blood lactic acid (also known as MALA). This rare but severe side effect is particularly risky for those with kidney problems, older adults, or heavy alcohol users. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Met G 2mg/500mg Tablet ER and seek immediate medical attention.
Met G 2mg/500mg Extended-Release tablets combine glimepiride and metformin to manage type 2 diabetes. This combination improves blood sugar control in adults when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 diabetes.
Met G 2mg/500mg Tablet ER may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Met G 2mg/500mg Tablet ER can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Metformin-glimepiride (Met G 2mg/500mg ER) can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Met G 2mg/500mg ER tablets and alcohol is unsafe. Alcohol can lower blood sugar, potentially causing hypoglycemia, and increase the risk of lactic acidosis.
Met G 2mg/500mg Tablet ER
66
MRP 80
17% off